BIOPIX-T

Private

HeraklionHealthcare & Life Scienceshttps://biopix-t.com/

Last Round

Debt

Jun 7, 2023

Total Funding Raised

$4.63M

Company Overview

BIOPIX-T is a diagnostic equipment company that develops novel portable molecular devices designed for point-of-care diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

point of care testingmolecular diagnosticsPOC testinghandheld diagnosticsrapid diagnosticsinfectious disease testingLAMP testingnucleic acid amplificationlab on a chipmedical devicesfood safety testingenvironmental monitoringrazor and blades modelCOVID-19 testingdiagnostic assay development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BIOPIX-T Comps

Public and private peers based on sector, stage, and business model.

BIOPIX-T comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BIOPIX-T Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jun 7, 2023
Seed	Apr 7, 2021
Grant	Sep 2, 2020
Grant	Nov 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

George Papadakis

Co-founder & Chief Executive Officer

Founding Team

KONSTANTINOS CHATZAKIS

Chief Financial Officer

Executive Team

BIOPIX-T Investors

Notable investors and investment history

BIOPIX-T investors
Investor	Rounds
Patras Science Park	Grant
Eleven	Debt, Seed
SeedBlink	Debt
Metavallon	Debt, Seed
European Union	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 14, 2025
Grew 20% QoQ, from 15 to 18 employees.
May 4, 2025
Monthly visitors grew 279% MoM, reaching 2K.

View all signals

BIOPIX-T Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BIOPIX-T Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BIOPIX-T's valuation, stock price, and market status.

Firmographic Details

HeadquartersHeraklion

Employee Range17

Year Founded2019

Last FundingJun 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.